MORGAN STANLEY PLC/CALL/CVS HEALTH/75/0.1/20.12.24 Stock

Warrant

DE000MB43SU8

Market Closed - Börse Stuttgart 14:56:41 2024-07-03 EDT
0.079 EUR -13.19% Intraday chart for MORGAN STANLEY PLC/CALL/CVS HEALTH/75/0.1/20.12.24
Current month-11.65%
1 month-22.88%
Date Price Change
24-07-03 0.079 -13.19%
24-07-02 0.091 -6.19%
24-07-01 0.097 -5.83%
24-06-28 0.103 +14.44%
24-06-27 0.09 -26.23%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 02:56 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
Issuer Morgan Stanley
WKN MB43SU
ISINDE000MB43SU8
Date issued 2023-03-03
Strike 75 $
Maturity 2024-12-20 (170 Days)
Parity 10 : 1
Emission price 1.91
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.6
Lowest since issue 0.056
Delta0.14x
Omega 9.087
Premium33.84x
Gearing63.74x
Moneyness 0.7560
Difference Strike 18.3 $
Difference Strike %+24.40%
Spread 0.007
Spread %8.14%
Theoretical value 0.0825
Implied Volatility 34.66 %
Total Loss Probability 90.21 %
Intrinsic value 0.000000
Present value 0.0825
Break even 75.89 €
Theta-0.01x
Vega0.01x
Rho0x

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
56.7 USD
Average target price
69.1 USD
Spread / Average Target
+21.86%
Consensus